Online citations, reference lists, and bibliographies.
← Back to Search

Efficacy, Tolerability And Safety Of Once-monthly Administration Of 75mg Risedronate In Japanese Patients With Involutional Osteoporosis: A Comparison With A 2.5mg Once-daily Dosage Regimen

Hiroshi Hagino, Hideaki Kishimoto, Hiroaki Ohishi, Sayako Horii, Toshitaka Nakamura

Cite This
Download PDF
Analyze on Scholarcy
Share